{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T18:40:05Z","timestamp":1747248005020,"version":"3.40.5"},"reference-count":116,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmaceutical Development and Technology"],"published-print":{"date-parts":[[2025,4,21]]},"DOI":"10.1080\/10837450.2025.2487575","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T10:20:59Z","timestamp":1743848459000},"page":"400-416","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Lessons learned from the COVID-19 pandemic: the intranasal administration as a route for treatment \u2013 a patent review"],"prefix":"10.1080","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8675-6233","authenticated-orcid":false,"given":"Nicole","family":"Menezes Pinto","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Federal University of Sergipe","place":["S\u00e3o Crist\u00f3v\u00e3o, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5466-8765","authenticated-orcid":false,"given":"Marcos Rafael","family":"das Chagas Mendon\u00e7a","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Federal University of Sergipe","place":["S\u00e3o Crist\u00f3v\u00e3o, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8772-9379","authenticated-orcid":false,"given":"Jeferson","family":"da Silva Santos","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Federal University of Sergipe","place":["S\u00e3o Crist\u00f3v\u00e3o, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6993-6195","authenticated-orcid":false,"given":"Camilla Martins","family":"dos Santos Ferraz","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Federal University of Sergipe","place":["S\u00e3o Crist\u00f3v\u00e3o, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3752-3142","authenticated-orcid":false,"given":"Daniela","family":"Santos Oliveira","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Federal University of Sergipe","place":["S\u00e3o Crist\u00f3v\u00e3o, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9811-7824","authenticated-orcid":false,"given":"L\u00edvia Vilas Boas","family":"dos Santos","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Federal University of Sergipe","place":["S\u00e3o Crist\u00f3v\u00e3o, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9665-9923","authenticated-orcid":false,"given":"Adriano Antunes","family":"de Souza Ara\u00fajo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Federal University of Sergipe","place":["S\u00e3o Crist\u00f3v\u00e3o, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5155-938X","authenticated-orcid":false,"given":"Lucindo","family":"Jos\u00e9 Quintans J\u00fanior","sequence":"additional","affiliation":[{"name":"Department of Physiology, Federal University of Sergipe","place":["S\u00e3o Crist\u00f3v\u00e3o, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0266-0702","authenticated-orcid":false,"given":"Divaldo Pereira","family":"Lyra J\u00fanior","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Federal University of Sergipe","place":["S\u00e3o Crist\u00f3v\u00e3o, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3192-8285","authenticated-orcid":false,"given":"Alfredo Dias","family":"de Oliveira Filho","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Federal University of Sergipe","place":["S\u00e3o Crist\u00f3v\u00e3o, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3451-9049","authenticated-orcid":false,"given":"Ana Am\u00e9lia Moreira","family":"Lira","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Federal University of Sergipe","place":["S\u00e3o Crist\u00f3v\u00e3o, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4223-3470","authenticated-orcid":false,"given":"Mairim","family":"Russo Serafini","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Federal University of Sergipe","place":["S\u00e3o Crist\u00f3v\u00e3o, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6681-2042","authenticated-orcid":false,"given":"Rog\u00e9ria","family":"de Souza Nunes","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Federal University of Sergipe","place":["S\u00e3o Crist\u00f3v\u00e3o, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"e_1_3_6_2_1","unstructured":"Abbott C Abbott DC. 2021. Copper ion composition and methods of treatment for conditions caused by coronaviruses and influenza. US11000545B2 issued 2021."},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121688"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-022-01251-1"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph15091068"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.4155\/tde-2023-0019"},{"key":"e_1_3_6_7_1","unstructured":"Cerny EH Vu CT Cerny T Cerny A. 2021. Methylene blue and riboflavin for prophylactic and therapeutic antiviral therapy. WO2021254928A1 issued 2021."},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.5802\/crbiol.8"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI126363"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103569"},{"key":"e_1_3_6_11_1","unstructured":"Chiarelli P Morini A Bettuzzi S Tachibana H Hara Y. 2021. Catechin-containing compositions and uses. WO2021210033A1 issued 2021."},{"key":"e_1_3_6_12_1","unstructured":"Chin C. 2021. Composition comprising gold nanoparticle as active ingredient for prevention or treatment of coronavirus-19. WO2021206187A1 issued 2021."},{"key":"e_1_3_6_13_1","unstructured":"Cl Z. 2021a. Composition methods of making and using for treating a viral infection including coronavirus infection. WO2021188614A1 issued 2021."},{"key":"e_1_3_6_14_1","unstructured":"Cl Z. 2021b. Composition methods of making and using for treating a viral infection including coronavirus infection. WO2021188614A9 issued 2021."},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00431"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2214293"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107614"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2022.110775"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2045853"},{"key":"e_1_3_6_20_1","unstructured":"Dong W Xie X Wen L Wang J Hu Y Li X Zhang L Ma C. 2021. Recombinant plasmid for use in prevention and treatment of SARS-CoV-2 infection recombinant lactobacillus expression system and application. WO2021208913A1 issued 2021."},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph17121742"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2021.01.017"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-024-02327-9"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1110467"},{"key":"e_1_3_6_25_1","unstructured":"Ferrer G. 2021. Antiviral & virucidal nasal spray compositions and related treatment methods. CA3176035A1 issued 2021."},{"key":"e_1_3_6_26_1","unstructured":"Ferrer G. 2022. Antiviral and virucidal lung nebulizer compositions and related treatment methods. US11395819B1 issued 2022."},{"key":"e_1_3_6_27_1","unstructured":"Gao VC Xie SC Wong. 2024. Composition for antiviral or oxidation pretreatment preparation method and usage method thereof. WO2024104313A1 issued 2024."},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.qref.2023.08.002"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.powtec.2023.118708"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.123809"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1128\/aem.01553-23"},{"key":"e_1_3_6_32_1","doi-asserted-by":"crossref","unstructured":"Hu J Wang R Zhou X Wu J Ping X Wang J Cao W Jin H Xu B. 2021. Compound herba hocttuyniae spray as well as preparation method and application thereof. CN113440563A issued 2021.","DOI":"10.1016\/j.focat.2021.10.033"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114239"},{"key":"e_1_3_6_34_1","unstructured":"Huang B. 2023. Use of Nitrogen-Containing Bisphosphonate in Combination with Glucocorticoid in Preventing or Treating Viral Pneumonia. JP2023075008A issued 2023."},{"key":"e_1_3_6_35_1","unstructured":"Huang CG Hussain A. 2021. Pharmaceutical formulation containing remdesivir and its active metabolites for dry powder inhalation. US2021353650A1 issued 2021."},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107843"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2024.105815"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2021.06.013"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42539-7"},{"key":"e_1_3_6_40_1","unstructured":"Ivashchenko AA Ivachtchenko AV Savchuk NF Ivachtchenko AA Loginov VG \u0422\u043e\u0440r M. 2021. SARS-CoV-2 antiviral drug antiprovir. WO2021221532A1 issued November 2021."},{"key":"e_1_3_6_41_1","unstructured":"Johnson LL. 2022. Methods of treating SARS-CoV-2 virus with protocatechuic acid. WO2022019997A1 issued January 2022."},{"key":"e_1_3_6_42_1","unstructured":"Josling P David S Bottomlwy L Scott. 2023. Compositions of high viscosity. GB2611803A issued 2023."},{"key":"e_1_3_6_43_1","unstructured":"Kalluri R. 2021. Compositions and methods for targeting coronaviruses using lipid vesicles including exosomes. CA3176614A1 issued 2021."},{"key":"e_1_3_6_44_1","unstructured":"Kelleher AD Ahlenstiel CLE Ledger S Bowden-Reid E Zhang Y. 2023. Antiviral SiRNA therapeutic for SARS-CoV-2. WO2024059910A1 issued March 28 2023."},{"key":"e_1_3_6_45_1","unstructured":"Keyser DJ Guillem AF Singh B Zager RA Ruiz S. 2021. Method for treatment of coronavirus infection. WO2021188787A1 issued 2021."},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X20666220507022701"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-021-00666-x"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.matpr.2022.11.213"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.2174\/2210303110999200526123006"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2022.12.019"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.1c05002"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02162-x"},{"key":"e_1_3_6_53_1","unstructured":"Latefi N. 2022. Glycyrrhizin for the treatment or prophylaxis of viral infection. WO2022051557A1 issued March 2022."},{"key":"e_1_3_6_54_1","unstructured":"Levetan C. 2021. Method of treating and preventing coronaviruses with low dosage interferon beta-1a as a Th17 inhibitor. US2021299226A1 issued 2021."},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bsheal.2023.08.003"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117390"},{"key":"e_1_3_6_57_1","unstructured":"Linhart RJ Zhang F Fareed J Jeske W. 2024. Nasal spray using pentosan polysulfate and mucopolysaccharide polysulfate for COVID-19 prevention and treatment. US2024066051A1 issued 2024."},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117412"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43630-022-00202-6"},{"key":"e_1_3_6_60_1","unstructured":"Lombardi MS Bulsara PA. 2022. Antiviral pharmaceutical composition. WO2022002867A1 issued January 2022."},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108004"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26237216"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115760"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103184"},{"key":"e_1_3_6_65_1","unstructured":"Mcleay M. 2021. Compositions containing verteporfin ribavirin gemcitabine or combinations thereof and methods of use for treating COVID-19 cancer or non-cancer diseases. US2021228485A1 issued July 2021."},{"key":"e_1_3_6_66_1","unstructured":"Mcleay M. 2023. Compositions containing verteporfin ribavirin gemcitabine or combinations thereof and methods of use for treating COVID-19 cancer or non-cancer diseases. US2023018580A1 issued January 2023."},{"key":"e_1_3_6_67_1","unstructured":"McMillan B Koontz T Berberich M Mandell A Kriston G Feliciano L Price E. 2022. Intranasal antiviral therapy for mucosal protection against virus infections. WO2022098525A9 issued 2022."},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.17605\/OSF.IO\/KWT49"},{"key":"e_1_3_6_69_1","unstructured":"Merchant S Patel M Duncan RE Fernanda de Andrade Fernandes M Jadhav VA. 2022. Interaction of SARS-CoV-2 proteins with molecular and cellular mechanisms of host cells and formulations to treat COVID-19. CA3189802A1 issued January 2022."},{"key":"e_1_3_6_70_1","unstructured":"Merchant S Patel M Duncan RE Fernanda de Andrade Fernandes M Jadhav VA. 2024. Interaction of SARS-CoV-2 proteins with molecular and cellular mechanisms of host cells and formulations to treat COVID-19. US2024024337A1 issued January 25 2024."},{"key":"e_1_3_6_71_1","unstructured":"Mohapatra S Mohapatra SS Mayilsamy K Markoutsa E McGill A. 2022a. Composition and method for treating COVID-19. WO2022232337A2 issued November 2022."},{"key":"e_1_3_6_72_1","unstructured":"Mohapatra S Mohapatra SS Mayilsamy K Markoutsa E McGill A. Composition and method for treating COVID-19. WO2022232337A3. 2022b. issued 2022."},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.0c03822"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237480"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2022.01.106"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100421"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113450"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104707"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41538-020-00078-9"},{"key":"e_1_3_6_80_1","unstructured":"Opanasopit P Patrojanasophon P Arunprasert K Aumklad P. 2023. Composition and methods for manufacturing nasal spray solution for the treatment and prevention of COVID-19. WO2023101616A1 issued June 2023."},{"key":"e_1_3_6_81_1","unstructured":"Ostrov DA Norris M. 2022. Diphenhydramine and lactoferrin for prevention and treatment of COVID-19. WO2022133455A1 issued June 2022."},{"key":"e_1_3_6_82_1","unstructured":"Patel H Kumar Sahoo B Saha S. 2021. Pharmaceutical ivermectin compositions. WO2021229514A1 issued November 2021."},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2023.106489"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-18513-0"},{"key":"e_1_3_6_85_1","unstructured":"Pizzocaro C. 2022. Antiviral agents for prevention or treatment of pathologies caused by alpha-and\/or beta-coranaviruses. WO2022137147A1 issued June 30 2022."},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17174"},{"key":"e_1_3_6_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116055"},{"key":"e_1_3_6_88_1","unstructured":"Pratap-Singh A Baldelli A Bacca M. 2023. Formulations and Methods for Protein Encapsulation by Spray Freeze Drying and Microencapsulated Compositions Thereof. WO2023235991A1 issued 2023."},{"key":"e_1_3_6_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.168"},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.0c02439"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2021.100063"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0272034"},{"key":"e_1_3_6_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-811924-2.00019-5"},{"key":"e_1_3_6_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfluchem.2021.109865"},{"key":"e_1_3_6_95_1","unstructured":"Seet CS. 2022. Composition and methods for the prevention and treatment of COVID-19 and respiratory illnesses. WO2022081093A1 issued 2022."},{"key":"e_1_3_6_96_1","doi-asserted-by":"publisher","DOI":"10.1080\/07388551.2021.1874283"},{"key":"e_1_3_6_97_1","unstructured":"Shikora D Hepburn J. 2021. Photooxidative inactivation of pathogens including SARS-CoV-2. GB2594763A issued November 2021."},{"key":"e_1_3_6_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27647"},{"key":"e_1_3_6_99_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-020-00459-8"},{"key":"e_1_3_6_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-08-102985-5.00025-5"},{"key":"e_1_3_6_101_1","unstructured":"Thoene J Gavin R. 2021. Cysteamine for the treatment of SARS-CoV-2 infection. WO2021231570A1 issued November 2021."},{"key":"e_1_3_6_102_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.79548"},{"key":"e_1_3_6_103_1","doi-asserted-by":"publisher","DOI":"10.1109\/TEM.2020.2996982"},{"key":"e_1_3_6_104_1","unstructured":"Tomas LM Faucillon EF. 2022a. Pharmaceutical composition for preventing or treating viral infections. WO2022038473A1 issued 2022."},{"key":"e_1_3_6_105_1","unstructured":"Tomas LM Faucillon EF. 2022b. Phytotherapeutic composition. GB2598160A issued 2022."},{"key":"e_1_3_6_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00816-7"},{"key":"e_1_3_6_107_1","unstructured":"Veja J. 2021. Delivery of aerosolized micromolar composition concentrations. WO2021247283A1 issued 2021."},{"key":"e_1_3_6_108_1","unstructured":"Veja JC. 2021. Novel preventive and therapeutic treatment for COVID-19 and any other disease caused by SARS-CoV-2. WO2021252254A1 issued 2021."},{"key":"e_1_3_6_109_1","unstructured":"WHO [World Health Organization]. 2021. Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern. Statment. 2021. https:\/\/www.who.int\/news\/item\/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern."},{"key":"e_1_3_6_110_1","unstructured":"WHO [World Health Organization]. 2024. COVID-19 epidemiological update \u2013 19 January 2024. 2024. https:\/\/www.who.int\/publications\/m\/item\/covid-19-epidemiological-update."},{"key":"e_1_3_6_111_1","unstructured":"Wissel S Rischer M Wissel P H\u00e4berlein F. 2023. Aqueous composition compromising avermectins. WO202313158A1 issued 2023."},{"key":"e_1_3_6_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.01.053"},{"key":"e_1_3_6_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121457"},{"key":"e_1_3_6_114_1","unstructured":"Zaid GH Wolf BA Moore RP Crow LD West JH. 2022. Formulations inhibiting SARS-CoV-2 virus. US2022175869A1 issued June 2022."},{"key":"e_1_3_6_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tifs.2022.12.012"},{"key":"e_1_3_6_116_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2012-7"},{"key":"e_1_3_6_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30418-5"}],"container-title":["Pharmaceutical Development and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10837450.2025.2487575","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T18:05:00Z","timestamp":1747245900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10837450.2025.2487575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":116,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4,21]]}},"alternative-id":["10.1080\/10837450.2025.2487575"],"URL":"https:\/\/doi.org\/10.1080\/10837450.2025.2487575","relation":{},"ISSN":["1083-7450","1097-9867"],"issn-type":[{"type":"print","value":"1083-7450"},{"type":"electronic","value":"1097-9867"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iphd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iphd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-07-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}